| P2093 | author name string | Opeolu Adeoye | |
| | Julio A Landero-Figueroa | |
| | Joseph Caruso | |
| | Phanichand Kodali | |
| P2860 | cites work | Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association | Q22241920 |
| | Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry | Q28204798 |
| | Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke | Q28212225 |
| | Protein kinase C-eta and phospholipase D2 pathway regulates foam cell formation via regulator of G protein signaling 2 | Q28507676 |
| | Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome | Q31137938 |
| | Characterization of the low molecular weight human serum proteome | Q31153810 |
| | Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR) | Q32049690 |
| | Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years | Q33966207 |
| | Candidate-based proteomics in the search for biomarkers of cardiovascular disease | Q35990040 |
| | Protein biomarker discovery and validation: the long and uncertain path to clinical utility | Q36561644 |
| | Multiple liquid chromatography separations and nanoESI-ion trap detection of plasma proteins in search of stroke biomarkers: A pilot study. | Q36571761 |
| | Blood biomarkers in the diagnosis of ischemic stroke: a systematic review | Q37227913 |
| | Blood markers for the prognosis of ischemic stroke: a systematic review | Q37415033 |
| | Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment | Q37635613 |
| | A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study | Q43787052 |
| | Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients | Q44053916 |
| | Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk | Q44374190 |
| | Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia | Q44590029 |
| | Plasma biomarkers in the diagnosis of acute ischemic stroke | Q45330979 |
| | Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. | Q46693663 |
| | Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites | Q46972135 |
| | Size-exclusion chromatography in multidimensional separation schemes for proteome analysis | Q47449192 |
| | Persistent inflammatory response in stroke survivors | Q47951893 |
| | Early Biomarkers of Stroke | Q48193653 |
| | The 1425G/A SNP in PRKCH is associated with ischemic stroke and cerebral hemorrhage in a Chinese population | Q48574552 |
| | Role of COL4A1 in small-vessel disease and hemorrhagic stroke | Q48591992 |
| | A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction | Q79500818 |
| | Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study | Q80475867 |
| | Fibrinogen gene variation and ischemic stroke | Q80846828 |
| | Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke | Q83401684 |
| P433 | issue | 10 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 1441-1445 | |
| P577 | publication date | 2013-04-13 | |
| P1433 | published in | Journal of Neural Transmission | Q15750921 |
| P1476 | title | A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection | |
| P478 | volume | 120 | |